Partner Content Partner Content Dr. Dana Carroll to deliver keynote on challenges in Program... 2nd Genome Editing & Engineering Conference is back!
News CRISPR Therapeutics plans Nasdaq launch CRISPR Therapeutics, the Swiss genome-editing company, has filed for a $90 million initial public offering.
News Fulcrum Therapeutics promises new drugs for rare disorders Company launched following $55 million series A funding round.
News Caribou gains $30m funding for CRISPR-Cas platform Genetic engineering specialist Caribou Biosciences has secured $30 million in a series B funding round.
Market Access Consolidating data strategy for global success: Insights fro... At Frontiers Health 2025, Drew McCormick, Head of Data and Analytics at EVERSANA, emphasised a critical truth: data strategy is launch strategy.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
